Literature DB >> 15877468

Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score.

Gang Chen1, Suxin Zheng, Xiaomin Luo, Jianhua Shen, Weiliang Zhu, Hong Liu, Chunshan Gui, Jian Zhang, Mingyue Zheng, Chum Mok Puah, Kaixian Chen, Hualiang Jiang.   

Abstract

The advent of focused library and virtual screening has reduced the disadvantage of combinatorial chemistry and changed it to a realizable and cost-effective tool in drug discovery. Usually, genetic algorithms (GAs) are used to quickly finding high-scoring molecules by sampling a small subset of the total combinatorial space. Therefore, scoring functions play essential roles in focused library design. Reported here is our initial attempt to establish a new approach for generating a target-focused library using the combination of the scores of structural diversity and binding affinity with our newly improved drug-likeness scoring functions. Meanwhile, a software package, named LD1.0, was developed on the basis of the new approach. One test on a cyclooxygenase (COX)2-focused library successfully reproduced the structures that have been experimentally studied as COX2-selective inhibitors. Another test is on a peroxisome proliferator-activated receptors gamma-focused library design, which not only reproduces the key fragments in the approved (thiazolidinedione) TZD drugs, but also generates some new structures that are more active than the approved drugs or published ligands. Both of the two tests took approximately 15% of the running time of the ordinary molecular docking method. Thus, our new approach is an effective, reliable, and practical way for building up a properly sized focused library with a high hit rate, novel structure, and good ADME/T profile.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15877468     DOI: 10.1021/cc049866h

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  8 in total

Review 1.  Computational drug discovery.

Authors:  Si-Sheng Ou-Yang; Jun-Yan Lu; Xiang-Qian Kong; Zhong-Jie Liang; Cheng Luo; Hualiang Jiang
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

2.  Increased diversity of libraries from libraries: chemoinformatic analysis of bis-diazacyclic libraries.

Authors:  Fabian López-Vallejo; Adel Nefzi; Andreas Bender; John R Owen; Ian T Nabney; Richard A Houghten; José L Medina-Franco
Journal:  Chem Biol Drug Des       Date:  2011-03-01       Impact factor: 2.817

3.  A physicochemical descriptor-based scoring scheme for effective and rapid filtering of kinase-like chemical space.

Authors:  Narender Singh; Hongmao Sun; Sidhartha Chaudhury; Mohamed Diwan M Abdulhameed; Anders Wallqvist; Gregory Tawa
Journal:  J Cheminform       Date:  2012-02-08       Impact factor: 5.514

4.  New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery.

Authors:  Yun Tang; Weiliang Zhu; Kaixian Chen; Hualiang Jiang
Journal:  Drug Discov Today Technol       Date:  2006

Review 5.  Selective Recognition of Amino Acids and Peptides by Small Supramolecular Receptors.

Authors:  Joana N Martins; João Carlos Lima; Nuno Basílio
Journal:  Molecules       Date:  2020-12-28       Impact factor: 4.411

Review 6.  Computational methods for drug design and discovery: focus on China.

Authors:  Mingyue Zheng; Xian Liu; Yuan Xu; Honglin Li; Cheng Luo; Hualiang Jiang
Journal:  Trends Pharmacol Sci       Date:  2013-09-11       Impact factor: 14.819

7.  Molecular Modeling, Synthesis and Biological Evaluation of N-Phenyl-4-Hydroxy-6-Methyl-2-Quinolone-3-CarboxAmides as Anticancer Agents.

Authors:  Dima A Sabbah; Shaima' E Hasan; Reema Abu Khalaf; Sanaa K Bardaweel; Rima Hajjo; Khalid M Alqaisi; Kamal A Sweidan; Aya M Al-Zuheiri
Journal:  Molecules       Date:  2020-11-16       Impact factor: 4.411

8.  Alkaloids from Cryptolepis sanguinolenta as Potential Inhibitors of SARS-CoV-2 Viral Proteins: An In Silico Study.

Authors:  Lawrence Sheringham Borquaye; Edward Ntim Gasu; Gilbert Boadu Ampomah; Lois Kwane Kyei; Margaret Amerley Amarh; Caleb Nketia Mensah; Daniel Nartey; Michael Commodore; Abigail Kusiwaa Adomako; Philipina Acheampong; Jehoshaphat Oppong Mensah; David Batsa Mormor; Caleb Impraim Aboagye
Journal:  Biomed Res Int       Date:  2020-09-22       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.